FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

758 letters match. Newest first.

  1. EyePoint Pharmaceuticals, Inc.

    FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.

    High risk
  2. Eugia Pharma Specialities Limited

    FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.

    High risk
  3. BullyKamp Products LLC

    BullyKamp Products LLC marketed unapproved animal drugs with disease-treatment claims on its website, FDA says.

    High risk
  4. Top Dog Pet Store LLC dba The Bulldog Cartel

    Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.

    High risk
  5. Omega Tech Labs LLC

    Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.

    High risk
  6. Velocity Pharma LLC

    Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.

    High risk
  7. High Quality Organics, Inc.

    FDA warned High Quality Organics over ready-to-eat spices after finding weak pathogen controls and no pesticide-hazard reanalysis.

    High risk
  8. Cavalry Industries d/b/a Select Vape

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  9. Walmart, Inc.

    FDA warned Walmart over selling an unapproved 90% lactic acid chemical peel drug that can cause burns.

    High risk
  10. Amazon.com, Inc.

    FDA warns Amazon over selling two unapproved chemical peel drugs that can burn skin.

    High risk
  11. Criticare Technologies, Inc.

    FDA warns Criticare Technologies over patient monitors after finding unresolved CAPAs, weak design controls and supplier checks at its Warwick, Rhode Island plant.

    High risk
  12. Brassica Pharma Pvt. Ltd.

    FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.

    High risk
  13. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  14. Massachusetts Institute of Technology MIT

    FDA says MIT's review board for human research failed to make sure consent forms and meeting records met federal rules.

    Medium
  15. Optikem International Inc.

    FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.

    High risk
  16. PepsiCo, Inc.

    FDA warned PepsiCo after Salmonella Cubana was found at its Danville, Illinois Quaker Oats plant, prompting recalls of granola bars and cereals.

    High risk
  17. Choo's Enterprises Ltd

    FDA warns Barbados acidified foods maker Choo's Enterprises over missing scheduled processes for syrups and seasonings.

    High risk
  18. Sun Pharmaceutical Industries Limited

    FDA cited Sun Pharmaceutical Industries for inadequate cleaning and maintenance at its Dadra drug plant, risking cross-contamination, and for weak investigations.

    High risk
  19. Frozen Food Development, Inc.

    Frozen Food Development packed ready-to-eat frozen produce under rodent activity and lacked required pathogen controls.

    High risk
  20. Bimbo Bakeries USA, Inc.

    FDA says Bimbo Bakeries USA misbranded Sara Lee and Brownberry bread labels, listing sesame and tree nuts not in the products.

    Medium
  21. Indiana Lions Eye Bank, Inc. dba VisionFirst Indiana Lions Eye Bank

    Indiana Lions Eye Bank distributed ocular tissue from donors with sepsis after failing to screen them as ineligible.

    High risk
  22. Landy International

    FDA found Landy International’s OTC hand sanitizers adulterated after a 2023 inspection revealed missing testing, unsafe water, and data integrity failures.

    High risk
  23. Angela D. Ritter, M.D.

    FDA warns Dr. Angela Ritter over unauthorized dosing of an investigational drug and missing ethics-board review.

    High risk
  24. Neobiosis, LLC

    FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.

    High risk
  25. All Things Bunnies, Inc.

    All Things Bunnies markets Toltrazuril 5% Suspension as an unapproved new animal drug for coccidiosis.

    Medium
  26. totaltoltrazuril.com

    FDA warned totaltoltrazuril.com for selling Total Toltrazuril, an unapproved new animal drug, for coccidiosis and horse EPM.

    High risk
  27. Toltrazuril Shop

    Toltrazuril Shop sells unapproved toltrazuril animal drugs online for coccidiosis and EPM, FDA says.

    High risk
  28. Linessa Farms, LLC

    Linessa Farms markets unapproved toltrazuril animal drugs for coccidiosis, FDA warns after website review.

    High risk
  29. Genpro Imports & Export Inc.

    FDA warns Genpro Imports over missing FSVP records for imported produce and ginger.

    Medium
  30. Amin Trading Agency LLC

    FDA found Amin Trading Agency lacked required foreign supplier checks for imported Indian spice products, including Everest and Masala E Magic.

    Medium
  31. Safari Stem Cell, LLC

    FDA warned Safari Stem Cell for selling unapproved stem cell animal drugs made without required CGMP controls, including sterility testing.

    High risk
  32. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  33. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk
  34. Grupo Quimico SRL

    FDA warns Uruguay contract testing lab Grupo Quimico over data integrity failures, including unreported failing HPLC results.

    High risk
  35. Seatex, LLC

    Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.

    High risk
  36. Vintage Chemical Inc.

    FDA warned Vintage Chemical after an inspection found over-the-counter hand soap and sanitizer made on equipment shared with industrial cleaners.

    High risk
  37. Hunan Gagazui Food Co., Ltd.

    Hunan Gagazui Food Co., Ltd. processed U.S.-bound low-acid canned surimi soybean snacks outside its filed process and without required retort controls.

    High risk
  38. Hi-Pro Feeds, LLC

    Hi-Pro Feeds made medicated goat feed linked to goat deaths; FDA cited missing urea hazard controls and late report.

    High risk
  39. Spectrum Medical Ltd

    Spectrum Medical marketed Quantum perfusion devices beyond cleared uses and had corrective-action failures.

    High risk
  40. P.T. Sankei Medical Industries

    FDA warned P.T. Sankei Medical Industries over unapproved changes to its single-use sphygmomanometer and quality system violations.

    High risk
  41. Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.

    Dr Sankunni's Ayurvedic Research Foundation failed to correct drug listing and registration errors for its balms and hand sanitizer.

    Low
  42. C&T Dream Co., Ltd.

    C&T Dream failed CGMP (current good manufacturing practice) for its over-the-counter Dry Skin Healing Ointment, including identity testing and process validation.

    High risk
  43. Natco Pharma Limited

    FDA warned Natco Pharma of adulterated drugs after finding dirty equipment and weak investigations at an India plant.

    High risk
  44. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  45. Soulaire Corporation

    FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.

    High risk
  46. Appleton City Feed Service LLC

    FDA warned Appleton City Feed Service, a Missouri medicated feed mill, of pest, cross-contamination and drug-combination risks in animal feed.

    High risk
  47. Jiangsu Meifan Biotechnology Co. Ltd.

    FDA cites Jiangsu Meifan Biotechnology for OTC drug manufacturing-rule failures and import alert.

    High risk
  48. New India Bazar, Inc.

    FDA cites New India Bazar for missing FSVP and allergen hazard analysis after MAGGI noodle recall.

    High risk
  49. Kilitch Healthcare India Limited

    FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.

    High risk
  50. Antaria Pty. Ltd.

    FDA warned Antaria Pty. Ltd. about manufacturing quality failures in its active drug ingredient, including poor out-of-specification investigations and testing.

    High risk